We discuss Dr. Arthur Lazarus's latest book: Medicine on Fire: A Narrative Travelogue. https://www.amazon.com/Medicine-Fire-Arthur-Lazarus-MBA/dp/1663257272 Arthur Lazarus is a former Doximity ...
We speak with Miss Tiffany Ryder about her experiences treating patients in rural emergency departments and her thoughts on future ...
We speak with Dr. Steven Charlap, a highly accomplished physician entrepreneur who's the CEO and founder of Soap Health: https://soap.health/ ...
We speak with Dr. Una, founder of EntreMD and the EntreMD business school, the only business school for physician entrepreneurs ...
We speak with Dr. Arlen Meyers, founder of Society of Physician Entrepreneurs (SoPE) about his entrepreneurial journey and why he ...
We speak with Miss Barby Ingle, candidate for Arizona State Legislature. To learn more about her, please select the following ...
Daily Remedy is proud to announce a partnership with Real Clear Politics (RCP). We will present RCP healthcare polls and ...
We speak with Dr. Brittany Busse and learn about her new startup, ViTel Health Dr. Brittany Busse has over five ...
Robyn’s career has spanned the medical device industry and includes director of clinical research administration, and regulatory and quality roles. ...
Dr. Jay K Joshi, editor of Daily Remedy, gives a presentation on implicit biases that appear when health providers decide ...
Launched in February 2023, the Health Care Litigation Tracker is a free digital resource that tracks and analyzes health care ...
Emily Ullrich is a former professor of Communication Arts and Founder of Nairobi Film Institute, a nonprofit organization she created ...
Can lowering tau biology translate into a clinically meaningful slowing of decline in people with early symptomatic Alzheimer’s disease? That is the practical question behind BIIB080, an intrathecal antisense therapy designed to reduce production of tau protein by targeting the tau gene transcript. In a phase 1b program originally designed for safety and dosing, investigators later examined cognitive, functional, and global outcomes as exploratory endpoints. The clinical question matters because current disease-modifying options primarily target amyloid, while tau pathology tracks...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy